Literature DB >> 26887218

Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study.

Wen Zhang1, Hiroyasu Iso, Yoshitaka Murakami, Katsuyuki Miura, Masato Nagai, Daisuke Sugiyama, Hirotsugu Ueshima, Tomonori Okamura.   

Abstract

AIM: To investigate the relationship between serum uric acid levels and cardiovascular disease in Asians.
METHODS: We examined the above relationship using the data of Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN Study). The data of 36,313 subjects (15,628 men and 20,685 women aged 35-89 years without histories of stroke, coronary heart disease, or cancer at baseline) were used for the analyses. Sex-specific hazard ratios (HRs) of mortality from cardiovascular disease were estimated according to the quintiles of serum uric acid using Cox hazard models stratified by cohorts.
RESULTS: During 441,771 person-years of follow-up, we documented 1,288 cardiovascular deaths. A J- or U-shaped relationship between serum uric acid level and cardiovascular disease mortality was observed. Compared with the lowest quintile of serum uric acid levels, the highest quintile was associated with an increased cardiovascular disease mortality in men [HR: 1.28; 95% confidence interval (CI): 1.01-1.63] and women (HR: 1.51; 95% CI: 1.14-1.99). However, there was no significant association with mortality from stroke, coronary heart disease or heart failure in both men and women.
CONCLUSION: This large pooled analysis in Japan suggested a J- or U-shaped relationship between serum uric acid levels and cardiovascular mortality. The highest quintile of serum uric acid levels was associated with increased cardiovascular disease mortality in both Japanese men and women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26887218     DOI: 10.5551/jat.31591

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  32 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort.

Authors:  Aniqa B Alam; Aozhou Wu; Melinda C Power; Nancy A West; Alvaro Alonso
Journal:  J Neurol Sci       Date:  2020-04-28       Impact factor: 3.181

3.  Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk.

Authors:  Lijun Li; Maoxiang Zhao; Chi Wang; Sijin Zhang; Cuijuan Yun; Si Chen; Liufu Cui; Shouling Wu; Hao Xue
Journal:  Clin Res Cardiol       Date:  2021-04-12       Impact factor: 5.460

Review 4.  Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities.

Authors:  Madugodaralalage D S K Gunaratne; Bjorg Thorsteinsdottir; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2021-05-13       Impact factor: 5.369

5.  Serum Uric Acid Revealed a U-Shaped Relationship With All-Cause Mortality and Cardiovascular Mortality in High Atherosclerosis Risk Patients: The ASSURE Study.

Authors:  Yan Cang; Shaojie Xu; Jingyin Zhang; Jingyi Ju; Zijun Chen; Keke Wang; Jue Li; Yawei Xu
Journal:  Front Cardiovasc Med       Date:  2021-05-24

Review 6.  Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.

Authors:  Hitoshi Nishizawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Hypertens Res       Date:  2022-01-19       Impact factor: 3.872

7.  Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.

Authors:  Masato Furuhashi; Yukimura Higashiura; Masayuki Koyama; Marenao Tanaka; Takayo Murase; Takashi Nakamura; Seigo Akari; Akiko Sakai; Kazuma Mori; Hirofumi Ohnishi; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Hypertens Res       Date:  2021-06-11       Impact factor: 3.872

8.  Anti-Hyperuricemic Effect of Iron Oxide Nanoparticles against Monosodium Urate Crystals Induced Gouty Arthritis in BALB/c Mice.

Authors:  Mubin Mustafa Kiyani; Nurain Baig Moghul; Maisra Azhar Butt; Hamza Rehman; Ramsha Masood; Tausif Ahmed Rajput; Syed Ali Imran Bokhari
Journal:  Biol Trace Elem Res       Date:  2021-07-01       Impact factor: 3.738

9.  No association between serum uric acid and lumbar spine bone mineral density in US adult males: a cross sectional study.

Authors:  Xiaoli Li; Lianju Li; Lixian Yang; Jiaxun Yang; Hua Lu
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

10.  Hypouricemia and Mortality Risk in the US General Population.

Authors:  Kristin M D'Silva; Chio Yokose; Na Lu; Natalie McCormick; Hwajeong Lee; Yuqing Zhang; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07-12       Impact factor: 5.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.